We observed that IGF2BP3 promoted proliferation in vivo (Fig. 2F, G; Fig. S1F) and metastatic invasive ability (Fig. 2H; Fig. S1F) in pancreatic cancer. Here, IGF2BP3 is linked to familial pancreatic carcinoma.